These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7885050)

  • 1. 5q-syndrome presenting as essential thrombocythemia: myelodysplastic syndrome or chronic myeloproliferative disorders?
    Koike T; Uesugi Y; Toba K; Narita M; Fuse I; Takahashi M; Shibata A
    Leukemia; 1995 Mar; 9(3):517-8. PubMed ID: 7885050
    [No Abstract]   [Full Text] [Related]  

  • 2. MDS with del(5q) and associated cKIT D816V positive mastocytosis.
    Chan N; Tan SY; Opat S; Shortt J
    Pathology; 2012 Aug; 44(5):492-3. PubMed ID: 22777071
    [No Abstract]   [Full Text] [Related]  

  • 3. Bone marrow morphology in myelodysplastic syndrome associated with isolated del(5q).
    Naresh KN; Reid A
    Am J Hematol; 2010 Aug; 85(8):609-10. PubMed ID: 20658591
    [No Abstract]   [Full Text] [Related]  

  • 4. Myeloid neoplasm with isolated del(5q) and the MPLW515L mutation fulfills the WHO diagnostic criteria for ET.
    Kirito K
    Int J Hematol; 2020 Aug; 112(2):238-242. PubMed ID: 32246278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Myelodysplastic syndrome associated with 5q deletion, review of 3 cases].
    Khanfir A; Frikha M; Mseddi S; Elloumi M; Daoud J; Makni F; Amouri A; Gargouri J; Saad A; Souissi T
    Tunis Med; 1997 Mar; 75(3):127-31. PubMed ID: 9506035
    [No Abstract]   [Full Text] [Related]  

  • 6. Deletion of the long arm of chromosome 5 in essential thrombocythemia.
    Reis MD; Sher GD; Lakhani A; Dubé ID; Senn JS; Pinkerton PH
    Cancer Genet Cytogenet; 1992 Jul; 61(1):93-5. PubMed ID: 1638486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytogenetic features of 5q deletion and 5q- syndrome in myelodysplastic syndrome in Korea; marker chromosomes proved to be chromosome 5 with interstitial deletion by fluorescence in situ hybridization.
    Lee HR; Oh B; Hong DS; Zang DY; Yoon HJ; Kim HJ; Kim I; Ahn JS; Cheong JW; Lee KA; Cho KS; Lee MH; Bang SM; Kim TY; Yun YM; Min YH; Lee YK; Lee DS;
    Cancer Genet Cytogenet; 2010 Dec; 203(2):193-202. PubMed ID: 21156233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5q- syndrome presenting chronic myeloproliferative disorders-like manifestation: a case report.
    Takahashi H; Furukawa T; Hashimoto S; Kanazawa N; Satoh N; Suzuki N; Takizawa J; Uesugi Y; Takahashi M; Aizawa Y; Koike T
    Am J Hematol; 2000 Jun; 64(2):120-3. PubMed ID: 10814992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of lenalidomide treatment and complete cytogenetic remission in a case of myelodysplastic syndrome with del(5q) and del(9q).
    Xiong B; Liu X; Zou P; Fan L; Chen W; Li W; Liu L
    Leuk Res; 2010 Jul; 34(7):e169-72. PubMed ID: 20122730
    [No Abstract]   [Full Text] [Related]  

  • 10. Myelodysplastic syndromes associated with interstitial deletion of chromosome 5q: clinicopathologic correlations and new insights from the pre-lenalidomide era.
    Holtan SG; Santana-Davila R; Dewald GW; Khetterling RP; Knudson RA; Hoyer JD; Chen D; Hanson CA; Porrata L; Tefferi A; Steensma DP
    Am J Hematol; 2008 Sep; 83(9):708-13. PubMed ID: 18634051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromosome 20 deletions in myelodysplastic syndromes and Philadelphia-chromosome-negative myeloproliferative disorders: characterization by molecular cytogenetics of commonly deleted and retained regions.
    Douet-Guilbert N; Basinko A; Morel F; Le Bris MJ; Ugo V; Morice P; Berthou C; De Braekeleer M
    Ann Hematol; 2008 Jul; 87(7):537-44. PubMed ID: 18350294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Essential thrombocythemia with deleted 5q--a genetic and morphologic hybrid?
    Wong KF; Yu PH; Wong WS
    Cancer Genet Cytogenet; 2010 Aug; 201(1):39-41. PubMed ID: 20633767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytogenetic analysis in patients with myelodysplastic syndrome.
    Hu N; Bian M
    Proc Chin Acad Med Sci Peking Union Med Coll; 1990; 5(3):135-9. PubMed ID: 2098765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Apropos of the case "Erythroblastopenia associated with myelodysplastic syndrome"].
    Aventín A
    Sangre (Barc); 1996 Dec; 41(6):483. PubMed ID: 9148428
    [No Abstract]   [Full Text] [Related]  

  • 15. Hematology problem. Myeloproliferative disorders.
    Saumur JH; Coleman ML; Larson LM
    Am J Med Technol; 1979 Jul; 45(7):634-7. PubMed ID: 573066
    [No Abstract]   [Full Text] [Related]  

  • 16. Myelodysplastic syndrome with isolated 5q deletion (5q- syndrome). A clonal stem cell disorder characterized by defective ribosome biogenesis.
    Cazzola M
    Haematologica; 2008 Jul; 93(7):967-72. PubMed ID: 18591621
    [No Abstract]   [Full Text] [Related]  

  • 17. The WHO classification of the myelodysplastic syndromes.
    Bain B
    Exp Oncol; 2004 Sep; 26(3):166-9. PubMed ID: 15494682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysgranulopoiesis is an independent adverse prognostic factor in chronic myeloid disorders with an isolated interstitial deletion of chromosome 5q.
    Chen D; Hoyer JD; Ketterling RP; Tefferi A; Steensma DP; Holtan SG; Santana-Davila R; Porrata LF; Dewald GW; Hanson CA
    Leukemia; 2009 Apr; 23(4):796-800. PubMed ID: 18946493
    [No Abstract]   [Full Text] [Related]  

  • 19. The 5q- syndrome.
    Giagounidis AA; Aul C
    Cancer Treat Res; 2008; 142():133-48. PubMed ID: 18283785
    [No Abstract]   [Full Text] [Related]  

  • 20. Very short-term lenalidomide treatment associated with durable resolution of anemia in a patient with myelodysplastic syndrome with chromosome 5q deletion.
    Cannella L; Latagliata R; Breccia M; Carmosino I; Loglisci G; Volpicelli P; Ferretti A; Santopietro M; Vozella F; Girmenia C; Cuzzola M; Oliva EN; Alimena G
    Ann Hematol; 2012 Feb; 91(2):309-10. PubMed ID: 21625998
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.